Cargando…
Neurotoxicity: A Rare Side Effect of Programmed Cell Death 1 (PD-1) Inhibitors
Immunotherapy is a biological therapy that helps the body’s immune system to fight against cancer cells. The Food and Drug Administration (FDA) approved the first immune checkpoint inhibitor in 2011. Since 2011, many immune checkpoint inhibitors have been approved. Programmed cell death 1 (PD-1) inh...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957660/ https://www.ncbi.nlm.nih.gov/pubmed/35355539 http://dx.doi.org/10.7759/cureus.22584 |